Ventana Medical Systems Inc

Type: Company
Name: Ventana Medical Systems Inc
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development

(NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Epic Sciences announced the appointment of Pascal Bamford, Ph.D. as vice president of product development. Dr. Bamford has more than 15 years of experience in developing complex, automated ... [Published NewsRX - Apr 18 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

2014 Healthcare Leadership Awards Winners

They are the people we turn to when we need them the most. They help heal our wounds. They mend our children. They have the ability to create happy endings for tragic stories. They impact the communities they serve in ways that few other professions can. ... [Published Arizona Business Magazine - Apr 11 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Epic Sciences appoints vice president of product development

Epic Sciences, Inc., a cancer diagnostics company, has appointed Pascal Bamford as vice president of product development. Prior to joining Epic Sciences, Dr Bamford served as senior project leader for Advanced Staining Assays at Ventana Medical Systems, ... [Published Individual.com - Apr 11 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate program

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced that it has entered into an agreement with Genmab A/S, Copenhagen, Denmark for the development ... [Published NewsRX - Apr 11 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Ventana and Genmab partner to develop IHC companion diagnostic tools

Ventana Medical Systems, Inc., a member of the Roche Group, has entered into an agreement with Genmab A/S, a biotechnology company, for the development of immunohistochemistry, or IHC, companion diagnostic tools for Genmab's HuMax-TF-ADC antibody drug ... [Published Individual.com - Apr 09 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Global Companion Diagnostics Market 2014-2018

Reportstack Announces the Publication of its Research Report -  . The following companies are the key players in Global Companion Diagnostics Market: Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Qiagen N.V., Roche Holding AG, 20/20 Genesystems ... [Published PitchEngine - Apr 04 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

Ventana signs companion diagnostic agreement with international biotech for antibody drug conjugate program

TUCSON, Ariz., April 3, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into an agreement with Genmab A/S, Copenhagen, Denmark for the development of companion diagnostic tools ... [Published PR Newswire: Financial Services - Apr 03 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Ventana supports World Health Organization's global classification of haematopoietic and lymphoid cancers

By a News Reporter-Staff News Editor at Clinical Trials Week -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group has made an educational grant to support the World Health Organization (WHO) Clinical Advisory Meeting being held March ... [Published 4 Traders - Apr 02 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 2 reports

Ventana supports World Health Organization's global classification of haematopoietic and lymphoid cancers

/PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group has made an educational grant to support the World Health Organization (WHO) Clinical Advisory Meeting being held March 31 through April 1, 2014 in Chicago. The meeting's ... [Published TickerTech.com - Mar 27 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 2 reports

Oro Valley Town Talk - 40 never looked so good

Next month, the Town of Oro Valley will mark its 40th Anniversary since incorporation in 1974. What began as a small community of 2.4 square miles and a population of 1,200 has grown to a thriving town of 36 square miles and more than 41,000 residents. ... [Published Northwest Explorer - Mar 19 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 2 reports

Former Gen-Probe CEO Partners with PE Firm in Hunt for Buyout Deals

Carl Hull, who was Gen-Probe CEO when Bedford, MA-based Hologic agreed to pay $3.7 billion to acquire the San Diego diagnostics company in 2012, has embarked on a new venture backed by GTCR, the Chicago private equity firm.Hull and Eric Tardif, a former ... [Published Xconomy - Mar 19 2014]
First reported Mar 18 2014 - Updated Mar 18 2014 - 2 reports

GTCR to invest up to $300 mln in Maravai

GTCR has teamed up with Carl Hull and Eric Tardif to launch Maravai Life Sciences . Based in San Diego, Calif., Marvai will focus on acquiring companies and products in the diagnostics and life sciences sector. Hull and Tardit are the former CEO and ... [Published PE Hub Blog - Mar 18 2014]

Quotes

"We are pleased to work with Genmab to develop a companion diagnostic for HuMax-TF-ADC," said Ventana President Mara G Aspinall. "This agreement is in 100% alignment with our CDx strategy and our ever-growing lineup of global pharma partnerships designed to bring promising therapies to market faster to improve the lives of cancer patients."
...at the intersection of engineering, biology and commercial product development," said Murali Prahalad, Ph D , president and CEO of Epic Sciences. "At Epic, Pascal will apply his vision and experience to innovate and automate Epic's circulating tumor cell technology platform. Our goal is to provide rapid detection of cancer and its genetic and molecular changes throughout a patient's journey, from matching patients to therapies to monitoring for resistance, so the best treatment path can be chosen at every clinical decision point."
Reporters obtained the following quote from the background information supplied by the inventors: "A wide variety of methods have been developed for linking molecules together to form conjugates. Of particular interest are biomolecular conjugates that are typically prepared to combine the functionalities of the joined molecules into one construct. One type of biomolecular conjugate combines a biomolecule that specifically binds to another molecule (such as a nucleic acid, an antibody, a lectin or an avidin) and a detectable label (such as a fluorescent label, fluorescent nanoparticle or an enzyme)."
"We are delighted to have Dr. Roche on board as he brings a wealth of senior scientific and leadership experience for IVD companion diagnosticdiagnostic assay development" commented TJ Johnson, HTG President and CEO

More Content

All (58) | News (46) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (2) | Press Releases (3)
sort by: Date | Relevance
Roche Ups Its Ante in Molecular POC Testing [Published Medical Design Technology - Apr 21 2014]
Epic Sciences Appoints Pascal Bamford, Ph.D. as... [Published NewsRX - Apr 18 2014]
Global Companion Diagnostics Market 2014-2018 w... [Published Individual.com - Apr 16 2014]
The Pathology of Severe Dengue in Multiple Orga... [Published PLoS medicine - Apr 15 2014]
Ventana Signs CDx Agreement with Genmab Antibod... [Published Advance for Administrators of the Laboratory - Apr 15 2014]
Ventana Signs Companion Diagnostic Agreement fo... [Published Biotech Daily - Apr 14 2014]
HPV testing market dominated by bioMérieux SA.,... [Published PR inside - Apr 11 2014]
2014 Healthcare Leadership Awards Winners [Published Arizona Business Magazine - Apr 11 2014]
Epic Sciences appoints vice president of produc... [Published Individual.com - Apr 11 2014]
Ventana signs companion diagnostic agreement wi... [Published NewsRX - Apr 11 2014]
Patent Issued for Molecular Conjugate [Published 4 Traders - Apr 10 2014]
Patrick Roche, Ph.D. Joins HTG Molecular Diagno... [Published MarketWired - Apr 09 2014]
Ventana and Genmab partner to develop IHC compa... [Published Individual.com - Apr 09 2014]
Epic Sciences Appoints Pascal Bamford, Ph.D. as... [Published Individual.com - Apr 08 2014]
Companion Diagnostics Market 2018: Genomics & P... [Published PRWeb - Apr 08 2014]
Roche's Ventana pairs with Genmab on yet anothe... [Published Fierce CRO - Apr 07 2014]
Global Companion Diagnostics Market 2014-2018 [Published PitchEngine - Apr 04 2014]
Ventana signs companion diagnostic agreement wi... [Published PR Newswire: Financial Services - Apr 03 2014]
A PhD Less Ordinary [Published University of Arizona - Apr 03 2014]
Ventana supports World Health Organization's gl... [Published 4 Traders - Apr 02 2014]
Ventana supports World Health Organization's gl... [Published TickerTech.com - Mar 27 2014]
Ventana supports World Health Organization's gl... [Published PR Newswire: Financial Services - Mar 27 2014]
Leading Medical Sales and Marketing Executive t... [Published Benzinga.com - Mar 27 2014]
Patent Issued for Digital Microscope Slide Scan... [Published 4 Traders - Mar 27 2014]
Pfizer's targeted Xalkori outshines chemo in tr... [Published FiercePharma - Mar 26 2014]
ROCHE BEARER SHARE : Ventana Benchmark XT Maint... [Published 4 Traders - Mar 23 2014]
Roche Bearer Share : Jack Phillips guides Roche... [Published 4 Traders - Mar 22 2014]
A Brief History Lesson on Obama and Companion D... [Published Medical Design Technology - Mar 21 2014]
GTCR Teams with Carl Hull and Eric Tardif to Cr... [Published PredictWallStreet - Mar 21 2014]
Oro Valley Town Talk - 40 never looked so good [Published Northwest Explorer - Mar 19 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Ventana signs companion diagnostic agreement wi... [Published PR Newswire: Financial Services - Apr 03 2014]
TUCSON, Ariz., April 3, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into an agreement with Genmab A/S, Copenhagen, Denmark for the development of companion diagnostic tools ...
Ventana supports World Health Organization's gl... [Published PR Newswire: Financial Services - Mar 27 2014]
TUCSON, Ariz., March 27, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group has made an educational grant to support the World Health Organization (WHO) Clinical Advisory Meeting being held March 31 through April ...
GTCR to invest up to $300 mln in Maravai [Published PE Hub Blog - Mar 18 2014]
GTCR has teamed up with Carl Hull and Eric Tardif to launch Maravai Life Sciences . Based in San Diego, Calif., Marvai will focus on acquiring companies and products in the diagnostics and life sciences sector. Hull and Tardit are the former CEO and ...
Ventana and Bayer Extend Collaboration [Published PR Newswire: Health - Mar 11 2014]
TUCSON, March 11, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into a multi-year agreement with Bayer Pharma AG (Bayer) to develop companion diagnostics, with a focus on ...
Podcast: How connectivity can help deliver bett... [Published GigaOM - Nov 12 2013]
A lot of people think of connectivity in their products as an opportunity to make things more efficient. That’s a primary reason that Ventana Medical systems added connectivity to one of its products in 2006. The idea was to use a wired connection in ...
1 2

Press Releases

sort by: Date | Relevance
Ventana Medical Systems, Inc., Convenes Interna... [Published Financial Services - Feb 25 2014]
Ventana announces HER2 companion diagnostic to ... [Published Financial Services - Dec 13 2013]
Ventana to partner with Incyte on the developme... [Published Financial Services - Nov 05 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.